Interaction of RANTES with syndecan-1 and syndecan-4 expressed by human primary macrophages

Biochimica et Biophysica Acta - Biomembranes

Volumn 1617, Issue 1-2, 2003, Pages 80-88

  Slimani, Hocine ^a,b   Charnaux, Nathalie ^a,b   Mbemba, Elisabeth ^a,b   Saffar, Line ^a,b   Vassy, Roger ^a,b   Vita, Claudio ^c   Gattegno, Liliane ^a,b  

^a UNIVERSITÉ PARIS 13   (France)

^b HÔPITAL JEAN VERDIER   (France)

^c CEA SACLAY   (France)

Author keywords

CCR5; HIV; Macrophage; RANTES; Syndecan

Indexed keywords

CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5; GLYCOSAMINOGLYCAN; HERMES ANTIGEN; RANTES; SYNDECAN; SYNDECAN 1; SYNDECAN 4; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MACROPHAGE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

EID: 0344154521     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2003.09.006     Document Type: Article

References (45)

1. Igarashi T., Brown C.R., Endo Y., Buckler-White A., Plishka R., Bischofberger N., Hirsch V., Martin M.A. Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans. Proc. Natl. Acad. Sci. U. S. A. 98:2001;658-663.
2. Wiley C.A., Schrier R.D., Nelson J.A., Lampert P.W., Oldstone M.B. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. U. S. A. 83:1986;7089-7093.
3. Appleman M.E., Marshall D.W., Brey R.L., Houk R.W., Beatty D.C., Winn R.E., Melcher G.P., Wise M.G., Sumaya C.V., Boswell R.N. Cerebrospinal fluid abnormalities in patients without AIDS who are seropositive for the human immunodeficiency virus. J. Infect. Dis. 158:1988;193-199.
4. Chun T.W., Carruth L., Finzi D., Shen X., DiGiuseppe J.A., Taylor H., Hermankova M., Chadwick K., Margolick J., Quinn T.C., Kuo Y.H., Brookmeyer R., Zeiger M.A., Barditch-Crovo P., Siliciano R.F. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. 387:1997;183-188.
5. Rich E.A., Chen I.S., Zack J.A., Leonard M.L., O'Brien W.A. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J. Clin. Invest. 89:1992;176-183.
6. Brooks D.G., Kitchen S.G., Kitchen C.M., Scripture-Adams D.D., Zack J.A. Generation of HIV latency during thymopoiesis. Nat. Med. 7:2001;459-464.
7. Pierson T., Hoffman T.L., Blankson J., Finzi D., Chadwick K., Margolick J.B., Buck C., Siliciano J.D., Doms R.W., Siliciano R.F. Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1. J. Virol. 74:2000;7824-7833.
8. Klatzmann D.R., McDougal J.S., Maddon P.J. The CD4 molecule and HIV infection. Immunodefic. Rev. 2:1990;43-66.
9. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., Berger E.A. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 272:1996;1955-1958.
10. Amara A., Gall S.L., Schwartz O., Salamero J., Montes M., Loetscher P., Baggiolini M., Virelizier J.L., Arenzana-Seisdedos F. HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 186:1997;139-146.
11. Bleul C.C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T.A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 382:1996;829-833.
12. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R.E., Hill C.M., Davis C.B., Peiper S.C., Schall T.J., Littman D.R., Landau N.R. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
13. Oberlin E., Amara A., Bachelerie F., Bessia C., Virelizier J.L., Arenzana-Seisdedos F., Schwartz O., Heard J.M., Clark-Lewis I., Legler D.F., Loetscher M., Baggiolini M., Moser B. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature. 382:1996;833-835.
14. Rabehi L., Seddiki N., Benjouad A., Gluckman J.C., Gattegno L. Interaction of human immunodeficiency virus type 1 envelope glycoprotein V3 loop with CCR5 and CD4 at the membrane of human primary macrophages. AIDS Res. Hum. Retrovir. 14:1998;1605-1615.
15. Amzazi S., Ylisastigui L., Bakri Y., Rabehi L., Gattegno L., Parmentier M., Gluckman J.C., Benjouad A. The inhibitory effect of RANTES on the infection of primary macrophages by R5 human immunodeficiency virus type-1 depends on the macrophage activation state. Virology. 252:1998;96-105.
16. Gordon C.J., Muesing M.A., Proudfoot A.E., Power C.A., Moore J.P., Trkola A. Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion. J. Virol. 73:1999;684-694.
17. Trkola A., Gordon C., Matthews J., Maxwell E., Ketas T., Czaplewski L., Proudfoot A.E., Moore J.P. The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity. J. Virol. 73:1999;6370-6379.
18. Chang T.L., Gordon C.J., Roscic-Mrkic B., Power C., Proudfoot A.E., Moore J.P., Trkola A. Interaction of the CC-chemokine RANTES with glycosaminoglycans activates a p44/p42 mitogen-activated protein kinase-dependent signaling pathway and enhances human immunodeficiency virus type 1 infectivity. J. Virol. 76:2002;2245-2254.
19. D'Souza M.P., Harden V.A. Chemokines and HIV-1 second receptors. Confluence of two fields generates optimism in AIDS research. Nat. Med. 2:1996;1293-1300.
20. Witt D.P., Lander A.D. Differential binding of chemokines to glycosaminoglycan subpopulations. Curr. Biol. 4:1994;394-400.
21. Middleton J., Neil S., Wintle J., Clark-Lewis I., Moore H., Lam C., Auer M., Hub E., Rot A. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell. 91:1997;385-395.
22. Kuschert G.S., Coulin F., Power C.A., Proudfoot A.E., Hubbard R.E., Hoogewerf A.J., Wells T.N. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry. 38:1999;12959-12968.
23. Mbemba E., Slimani H., Atemezem A., Saffar L., Gattegno L. Glycans are involved in RANTES binding to CCR5 positive as well as to CCR5 negative cells. Biochim. Biophys. Acta. 1510:2001;354-366.
24. Martin L., Blanpain C., Garnier P., Wittamer V., Parmentier M., Vita C. Structural and functional analysis of the RANTES-glycosaminoglycans interactions. Biochemistry. 40:2001;6303-6318.
25. Proudfoot A.E., Fritchley S., Borlat F., Shaw J.P., Vilbois F., Zwahlen C., Trkola A., Marchant D., Clapham P.R., Wells T.N. The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J. Biol. Chem. 276:2001;10620-10626.
26. Callahan L.N., Phelan M., Mallinson M., Norcross M.A. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions. J. Virol. 65:1991;1543-1550.
27. Carre V., Mbemba E., Letourneur D., Jozefonvicz J., Gattegno L. Interactions of HIV-1 envelope glycoproteins with derivatized dextrans. Biochim. Biophys. Acta. 1243:1995;175-180.
28. Oravecz T., Pall M., Wang J., Roderiquez G., Ditto M., Norcross M.A. Regulation of anti-HIV-1 activity of RANTES by heparan sulfate proteoglycans. J. Immunol. 159:1997;4587-4592.
29. Saphire A.C., Bobardt M.D., Zhang Z., David G., Gallay P.A. Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J. Virol. 75:2001;9187-9200.
30. Mbemba E., Gluckman J.C., Gattegno L. Glycan and glycosaminoglycan binding properties of stromal cell-derived factor (SDF)-1alpha. Glycobiology. 10:2000;21-29.
31. Mbemba E., Benjouad A., Saffar L., Gattegno L. Glycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1alpha with membrane ligands of CD4(+) CXCR4(+) cells. Virology. 265:1999;354-364.
32. Mbemba E., Saffar L., Gattegno L. Role of N-glycans and SDF-1alpha on the coassociation of CD4 with CXCR4 at the plasma membrane of monocytic cells and blood lymphocytes. FEBS Lett. 514:2002;209-213.
33. Jordan B.A., Devi L.A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature. 399:1999;697-700.
34. Brelot A., Heveker N., Pleskoff O., Sol N., Alizon M. Role of the first and third extracellular domains of CXCR4 in human immunodeficiency virus coreceptor activity. J. Virol. 71:1997;4744-4751.
35. Lapham C.K., Ouyang J., Chandrasekhar B., Nguyen N.Y., Dimitrov D.S., Golding H. Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science. 274:1996;602-605.
36. David G., Bai X.M., Van der Schueren B., Cassiman J.J., Van den Berghe H. Developmental changes in heparan sulfate expression: in situ detection with mAbs. J. Cell Biol. 119:1992;961-975.
37. Clasper S., Vekemans S., Fiore M., Plebanski M., Wordsworth P., David G., Jackson D.G. Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor action. J. Biol. Chem. 274:1999;24113-24123.
38. Roscic-Mrkic B., Fischer M., Leemann C., Manrique A., Gordon C.J., Moore J.P., Proudfoot A.E., Trkola A. RANTES (CCL5) utilizes the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement. Blood. 102:2003;1169-1177.
39. Goodison S., Urquidi V., Tarin D. CD44 cell adhesion molecules. Mol. Pathol. 52:1999;189-196.
40. Trebst C., Sorensen T.L., Kivisakk P., Cathcart M.K., Hesselgesser J., Horuk R., Sellebjerg F., Lassmann H., Ransohoff R.M. CCR1+/CCR5+mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. Am. J. Pathol. 159:2001;1701-1710.
41. Hoogewerf A.J., Kuschert G.S., Proudfoot A.E., Borlat F., Clark-Lewis I., Power C.A., Wells T.N. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry. 36:1997;13570-13578.
42. Samson M., LaRosa G., Libert F., Paindavoine P., Detheux M., Vassart G., Parmentier M. The second extracellular loop of CCR5 is the major determinant of ligand specificity. J. Biol. Chem. 272:1997;24934-24941.
43. 2+ signaling. J. Exp. Med. 188:1998;1917-1927.
44. Horowitz A., Simons M. Phosphorylation of the cytoplasmic tail of syndecan-4 regulates activation of protein kinase Calpha. J. Biol. Chem. 273:1998;25548-25551.
45. Oh E.S., Woods A., Couchman J.R. Multimerization of the cytoplasmic domain of syndecan-4 is required for its ability to activate protein kinase C. J. Biol. Chem. 272:1997;11805-11811.